�Leading ovarian cancer researchers and clinicians from around the earth will get together in Seattle September forty-five to discuss exciting new discoveries and recent scientific findings to fight ovarian cancer, which kills more than 15,000 women every class. The news media will get a sneak peek at these discoveries during a good morning news conference on September 4.
"Early detection of ovarian malignant neoplastic disease is one of the most critical factors to improving the prognosis for women diagnosed with this disease," aforesaid Nancy Sclater, Executive Director of the Marsha Rivkin Center for Ovarian Cancer Research. "This symposium will reveal advances being made in early detection which will be critical piece we search for a cure."
The two-day symposium will be held at the Pigott Auditorium on the campus of Seattle University and marks the beginning of Ovarian Cancer Awareness Month. More than 50 researchers will part their findings including the fact that ovarian cancer the Crab may not even get in the ovaries, newfangled research to use water tests for early detecting, and young strategies for improving drug penetration for patients diagnosed with ovarian cancer.
The symposium will also feature four keynote addresses from some of the brightest names in ovarian cancer research. On Thursday, Christopher Crum, MD, from Harvard Medical School, will discuss the origins of ovarian cancer, and Anil K. Sood, MD, from University of Texas, MD Anderson Cancer Center, will present on the development of therapeutics.
Friday's keynote presentations will lineament Maurie Markman, MD, too from University of Texas, MD Anderson Cancer Center, who will present his research on therapeutics. The last keynote address will cover enquiry on transmissible ovarian cancer the Crab, presented by local and well-renowned research worker Mary-Claire King, PhD, from the University of Washington.
A news conference with the keynote speakers, Sclater and Dr. Saul Rivkin is scheduled to kickoff the symposium at 9:30 a.m. on Thursday, Sept. 4. Details are below.
The Marsha Rivkin Center for Ovarian Cancer Research was founded in 1996 by Saul Rivkin, M.D., in memory of his wife wHO succumbed to ovarian cancer the Crab. It has been the catalyst for national and international research efforts aimed at finding solutions to ovarian cancer. The Center is dedicated to deliverance lives and reducing distress through improved treatment, early detection and prevention of ovarian cancer.
Marsha Rivkin Center for Ovarian Cancer Research
More info
